BRIEF published on 05/14/2025 at 10:05, 1 year 1 month ago Asklepios Group Reports Stable Performance in Q1 2025 Quarterly Results Financial Stability Patient Growth Asklepios Kliniken Healthcare Performance
PRESS RELEASE published on 05/14/2025 at 10:00, 1 year 1 month ago Asklepios Group: Stable business performance in Q1 2025 Asklepios Group reports stable business performance in Q1 2025 with 10.2% revenue increase and solid financial position. Consolidated net income up to EUR 22.5 million Revenue Increase Financial Position Net Income Asklepios Group Q1 2025
BRIEF published on 04/30/2025 at 10:05, 1 year 1 month ago Le groupe Asklepios publie son rapport CSRD 2024 Allemagne Soins De Santé Réalisations ESG Normes De Durabilité Rapport CSRD
BRIEF published on 04/30/2025 at 10:05, 1 year 1 month ago Asklepios Group Publishes CSRD Report 2024 Healthcare Germany Sustainability Standards ESG Achievements CSRD Report
PRESS RELEASE published on 04/30/2025 at 10:00, 1 year 1 month ago Asklepios Group: Publication of Asklepios CSRD Report 2024 Asklepios Kliniken GmbH & Co. KGaA publishes its audited CSRD Report for the financial year 2024, highlighting achievements in ESG/sustainability Sustainability Financial Year 2024 ESG Asklepios Kliniken CSRD Report
BRIEF published on 11/28/2024 at 10:05, 1 year 6 months ago Le groupe Asklepios annonce une croissance soutenue en 2024 Croissance 2024 Durabilité Soins De Santé Refinancement Asclépios
BRIEF published on 11/28/2024 at 10:05, 1 year 6 months ago Asklepios Group Reports Steady Growth in 2024 Sustainability Healthcare Refinancing Growth 2024 Asklepios
PRESS RELEASE published on 11/28/2024 at 10:00, 1 year 6 months ago Asklepios Group: Consistent growth in first nine months of 2024 Asklepios Group reports consistent growth in first nine months of 2024 with EUR 4,350.8 million revenue and 6% increase in patient numbers. Refinancing supports sustainability initiatives Revenue Refinancing Growth Asklepios Group Patient Numbers
BRIEF published on 11/06/2024 at 10:05, 1 year 7 months ago Asklepios obtient un prêt social Schuldschein de 500 millions d'euros Durabilité Demande Des Investisseurs Finances Sociales Prêt Schuldschein Infrastructures De Santé
BRIEF published on 11/06/2024 at 10:05, 1 year 7 months ago Asklepios Secures EUR 500 Million in Social Schuldschein Loan Sustainability Investor Demand Social Finance Schuldschein Loan Healthcare Infrastructure
Published on 06/26/2026 at 01:40, 9 hours 24 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 11 hours 34 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 12 hours 34 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 13 hours 32 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 19 hours 34 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 10:50, 14 minutes ago Indotek Group acquires remaining 53% stake in Auchan Hungary, assumes full ownership
Published on 06/26/2026 at 10:47, 17 minutes ago flatexDEGIRO accelerates its growth trajectory and expects to achieve its 2027 financial targets already in 2026, one year ahead of schedule
Published on 06/26/2026 at 10:44, 19 minutes ago EQS-Adhoc: flatexDEGIRO SE: Full-year 2026 guidance raised, financial targets originally set for 2027 expected to be achieved already in 2026, one year ahead of time
Published on 06/26/2026 at 10:30, 34 minutes ago Uniper and Skyborn Renewables sign offshore wind PPA
Published on 06/26/2026 at 10:25, 39 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Published on 06/26/2026 at 07:00, 4 hours 4 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 4 hours 4 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 16 hours 19 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 16 hours 34 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 17 hours 14 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
